European Perspectives on Life Sciences (Part I): Market Dynamics, Corporate Transaction Trends, Competition and Disputes Developments, Technology Trends

The life sciences industry is undergoing transformation across the globe and facing challenges and opportunities arising from the COVID-19 pandemic. In addition, the United Kingdom’s exit from the European Union has brought significant changes for the industry in relation to issues including pharmaceutical and medical device regulation, antitrust and competition, and corporate transactions.

Please join us for a two-part webinar series on key legal, employment, and regulatory trends and issues impacting the European life sciences market.

This first session will focus on corporate, commercial, antitrust, and litigation considerations.